Impact of nusinersen on the health‐related quality of life and caregiver burden of patients with spinal muscular atrophy with symptom onset after age 6 months
Muscle & Nerve · 2023
DOI: 10.1002/mus.27950 ↗Kurz gefasst
Fachartikel in der Zeitschrift Muscle & Nerve, 2023. Verfasst von Yun Jeong Lee und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Kyungpook National University Hospital and School of Medicine, Kyungpook National University, Daegu, South Korea. Hauptthemen laut MEDLINE: Caregiver Burden, Muscular Atrophy, Spinal. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Biogen.
Themen: Pflegende Angehörige
Abstract (Originalsprache)
Introduction/Aims Novel disease‐modifying approaches for spinal muscular atrophy (SMA) have highlighted the patient's perspective on functional changes over time. In this study, we evaluated the impact of nusinersen on the health‐related quality of life (HRQoL) of patients with later‐onset SMA and the caregiver burden.
Methods
We assessed the changes in HRQoL using the Pediatric Quality of Life Inventory 4.0 Generic Core Scale (PedsQL GCS) and the Pediatric Quality of Life Inventory 3.0 Neuromuscular Module (PedsQL NMM) during 26 months of treatment. Caregiver burden was assessed using the Assessment of Caregiver Experience with Neuromuscular Disease. We also assessed motor function using the Hammersmith Functional Motor Scale—Expanded (HFMSE) and the Revised Upper Limb Module score.
Results
Twenty‐four patients and their caregivers were included. The median age of patients at treatment onset was 148.8 (6.8 to 269.4) months. A significant improvement was observed in psychosocial health in proxy‐reported PedsQL ( P = .023). However, the physical health scores of the PedsQL GCS and About my neuromuscular disorder subscores of the PedsQL NMM did not change, although there was a significant increase in HFMSE scores. Regarding the caregiver burden, the financial burden was reduced, whereas time burden increased. A higher HFMSE score was associated with better self‐reported PedsQL GCS total scores ( P < .001).
Discussion
Our results provide insights into the multifaceted implications of disease‐modifying therapies for SMA through patient‐reported outcome measures (PROMs). PROMs should be taken into consideration to assess the clinical significance of the functional changes identified by clinician‐reported scales.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Kyungpook National University Hospital and School of Medicine, Kyungpook National University, Daegu, South Korea.
- Department of Rehabilitation Medicine, Kyungpook National University Hospital and School of Medicine, Kyungpook National University, Daegu, South Korea.
- Department of Neurology, Kyungpook National University Hospital and School of Medicine, Kyungpook National University, Daegu, South Korea.
- Department of Pediatrics, Korea University Ansan Hospital, Seoul, South Korea.
- Department of Pediatrics, Pediatric Clinical Neuroscience Center, Seoul National University Children's Hospital, Seoul National University College of Medicine, Seoul, South Korea.
- Department of Pediatrics, Kyungpook National University Children's Hospital, School of Medicine, Kyungpook National University, Daegu, South Korea.
ORCID-Profile: Yun Jeong Lee, Jong-Mok Lee
Förderung
- Biogen
Zitieren
APA
Lee, Y. J., Kim, A. R., Lee, J. M., Shim, Y. K., Cho, J. S., Ryu, H. W., Kwon, S., & Chae, J. H. (2023). Impact of nusinersen on the health‐related quality of life and caregiver burden of patients with spinal muscular atrophy with symptom onset after age 6 months. Muscle & Nerve. https://doi.org/10.1002/mus.27950
Vancouver
Lee YJ, Kim AR, Lee JM, Shim YK, Cho JS, Ryu HW, et al. Impact of nusinersen on the health‐related quality of life and caregiver burden of patients with spinal muscular atrophy with symptom onset after age 6 months. Muscle & Nerve. 2023. doi:10.1002/mus.27950
BibTeX
@article{Lee2023,
author = {Lee, Yun Jeong and Kim, Ae Ryoung and Lee, Jong-Mok and Shim, Young Kyu and Cho, Jae So and Ryu, Hye Won and Kwon, Soonhak and Chae, Jong-Hee},
title = {Impact of nusinersen on the health‐related quality of life and caregiver burden of patients with spinal muscular atrophy with symptom onset after age 6 months},
journal = {Muscle & Nerve},
year = {2023},
doi = {10.1002/mus.27950}
}
EUVIMED